Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, γ-IFN and IL-4) in vitro

Transplant Immunology

Volumn 9, Issue 1, 2001, Pages 1-6

  Zuo, Xiao Jing ^a   Nicolaidou, Electra ^a   Okada, Yoshinori ^a   Toyoda, Mieko ^a   Jordan, Stanley C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antithrombin III; Cell proliferation; Cytokine gene expression; Immunoglobulin production; Immunosuppression

Indexed keywords

ALPHA INTERFERON; ANTITHROMBIN III; CYTOKINE; CYTOKINE RECEPTOR; GROWTH FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; OKT 3;

ANIMAL CELL; ARTICLE; CELL CULTURE; EXPERIMENT; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; LUNG TRANSPLANTATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MITOGENICITY; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SPLEEN CELL; STIMULATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODY FORMATION; ANTITHROMBIN III; CELLS, CULTURED; CONCANAVALIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN;

EID: 0034797626     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(01)00042-9     Document Type: Article

References (23)

1. The endothelial heparin sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys
2. Natural anticoagulant pathways in normal and transplanted human hearts
3. Influence of high-dose antithrombin concentrates therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation
4. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation
5. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia
6. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III
7. Influence of antithrombin III on coagulation and inflammation in porcine septic shock
8. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection
9. The anti-inflammatory properties of antithrombin III: New therapeutic implications
10. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion
11. Antithrombin III treatment improves parameters of acute inflammation in a highly histoincompatable model of rat lung allograft rejection
12. Inhibition of allospecific responses in the mixed lymphocyte reaction by poled human gamma-globulin
13. Modulation of immunoglobulin production and cytokine mRNA expression in PBMCs by intravenous gamma-globulin
14. Prolongation of skin allograft survival is associated with reduced Th1 cytokine responses in the WKY- > F344 rat model
15. Cytokine gene expression in rejecting and tolerant rat lung allograft models: Analysis by RT-PCR
16. T-lymphocyte-antigen interactions in transplant rejection
17. Interleukin 2
18. Interleukin 4
19. The molecular cell biology of interferon-gamma and its receptor
20. Thrombin enhances T cell proliferation responses and cytokine production
21. Functional interactions between the thrombin receptor and T cell antigen receptor in human T cell lines
22. Protease-dependent T cell activation: Ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation
23. In vivo immunosuppression by targeting a novel protease receptor